Book contents
- Office Gynecology
- Office Gynecology
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pelvic Pain
- Section II Vaginal Discharge and Sexually Transmitted Infections
- Section III Amenorrhea and Abnormal Vaginal Bleeding
- Section IV Contraception and Abortion
- Section V Breast Problems
- Section VI Cancer Screening and Prevention
- Case 38 A 22-Year-Old Woman with LSIL on Initial Cervical Cytology
- Case 39 A 25-Year-Old Woman Who Has Received a Letter from an Aunt Recommending Lynch Testing (Cascade Testing)
- Case 40 A 30-Year-Old Woman with Positive Margins on LEEP for HSIL
- Case 41 A 32-Year-Old Woman Whose Paternal Aunt and Grandmother Had Ovarian Cancer
- Case 42 A 23-Year-Old Woman with HSIL on Cervical Cytology
- Case 43 A 35-Year-Old Woman with a Strong Family History of Breast Cancer Not Linked to BRCA Mutation
- Case 44 A 25-Year-Old Woman with LSIL Desiring HPV Vaccination
- Section VII Vulvar Disease
- Section VIII Infertility
- Section IX Preconception Planning
- Section X Pediatric and Adolescent Problems
- Section XI Pelvic Masses and Cysts
- Section XII Incontinence and Prolapse
- Section XIII Behavioral, Sexual, and Social Health
- Section XIV Managing and Aging
- Index
- References
Case 44 - A 25-Year-Old Woman with LSIL Desiring HPV Vaccination
from Section VI - Cancer Screening and Prevention
Published online by Cambridge University Press: 20 February 2019
Book contents
- Office Gynecology
- Office Gynecology
- Copyright page
- Contents
- Contributors
- Preface
- Section I Pelvic Pain
- Section II Vaginal Discharge and Sexually Transmitted Infections
- Section III Amenorrhea and Abnormal Vaginal Bleeding
- Section IV Contraception and Abortion
- Section V Breast Problems
- Section VI Cancer Screening and Prevention
- Case 38 A 22-Year-Old Woman with LSIL on Initial Cervical Cytology
- Case 39 A 25-Year-Old Woman Who Has Received a Letter from an Aunt Recommending Lynch Testing (Cascade Testing)
- Case 40 A 30-Year-Old Woman with Positive Margins on LEEP for HSIL
- Case 41 A 32-Year-Old Woman Whose Paternal Aunt and Grandmother Had Ovarian Cancer
- Case 42 A 23-Year-Old Woman with HSIL on Cervical Cytology
- Case 43 A 35-Year-Old Woman with a Strong Family History of Breast Cancer Not Linked to BRCA Mutation
- Case 44 A 25-Year-Old Woman with LSIL Desiring HPV Vaccination
- Section VII Vulvar Disease
- Section VIII Infertility
- Section IX Preconception Planning
- Section X Pediatric and Adolescent Problems
- Section XI Pelvic Masses and Cysts
- Section XII Incontinence and Prolapse
- Section XIII Behavioral, Sexual, and Social Health
- Section XIV Managing and Aging
- Index
- References
- Type
- Chapter
- Information
- Office GynecologyA Case-Based Approach, pp. 136 - 137Publisher: Cambridge University PressPrint publication year: 2019
References
Massad, LS, Einstein, MH, Huh, WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17(5 Suppl 1): S1–S27.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists. Human papillomavirus vaccination. Committee Opinion No. 704. Obstet Gynecol 2017; 129: e173–e178.Google Scholar
Markowitz, LE, Hariri, S, Lin, C et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National health and nutrition examination surveys, 2003–2010. J Infect Dis 2013;208(3):385–393.CrossRefGoogle ScholarPubMed
Khan, MJ, Castle, PE, Lorincz, AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97(14):1072–1079.Google Scholar
Munoz, N, Bosch, FX, de Sanjose, S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348(6):518–527.CrossRefGoogle ScholarPubMed
Viens, LJ, Henley, SJ, Watson, M et al. Human papillomavirus-associated cancers – United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016;65(26):661–666.CrossRefGoogle ScholarPubMed
Meites, E, Kempe, A, Markowitz, LE. Use of a 2-dose schedule for human papillomavirus vaccination – updated recommendations of the advisory committee on immunization practices.MMWR Morb Mortal Wkly Rep 2016;65(49):1405–1408.CrossRefGoogle ScholarPubMed
Olsson, SE, Kjaer, SK, Sigurdsson, K et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin 2009;5(10):696–704.Google Scholar
Markowitz, LE, Dunne, EF, Saraiya, M et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63(RR–05):1–30.Google ScholarPubMed
Vichnin, M, Bonanni, P, Klein, NP et al. An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015. Pediatr Infect Dis J 2015;34(9):983–991.Google Scholar